Abstract
The US Food and Drug Administration is committed to the continued evaluation of the safety, effectiveness, and availability of medical devices, including devices in high demand during the COVID-19 (coronavirus disease 2019) pandemic. Two recent US Food and Drug Administration communications, shared here, include resources and information that may impact the work of healthcare professionals and healthcare technology managers.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
